More Images
SAN RAMON, Calif.—Twenty eyecare professionals (ECPs) from across the U.S. are the first certified ODs to prescribe under CooperVision’s new Brilliant Futures Myopia Management Program, which features the MiSight 1 day contact lens as its cornerstone, according to an announcement. Following an in-person educational workshop covering clinical, technological, and child-parent interaction content, each of the 20 ODs then successfully completed an online exam. The CooperVision MiSight 1 day lens is the first and only product approved by the Food and Drug Administration (FDA) for slowing the progression of myopia in children, who at initiation of treatment are 8-12 years of age, as VMAIL reported.

“Congratulations to these history-making ECPs who are now certified to prescribe the Brilliant Futures Myopia Management Program in their practices,” said Michele Andrews, OD, senior director of North America Professional & Academic Affairs at CooperVision. “We are deeply committed to addressing the rising severity and prevalence of myopia progression. I’m elated so many of my fellow optometrists are eager to approach myopia management in a new way. Together, combining this type of innovative thinking with their professional expertise, we can achieve the best possible outcomes for our young patients.”

“Even though I’ve treated myopia for the last 15 years, I came away from the CooperVision training and certification process with new information and insights that will make a difference in how I practice,” said Roxanne Achong-Coan, OD, FAAO, FIAOMC, FSLS, of Coan Eye Care in Ocoee, Fla. “Successfully tackling myopia progression is more than just fitting a lens. It’s helping parents and children make and follow-through on a decision that has significant implications for the child’s vision, today and throughout their lives. The Brilliant Futures Myopia Management Program will be a great asset to my practice and for so many kids and families in the Orlando area.”

Added Mike Cymbor, OD, FAAO, of Nittany Eye Associates in State College, Pa., “What I learned while attending CooperVision’s inaugural launch event has me viewing myopia in a completely different way. Myopia is a disease. If a child has a certain amount of myopia, it can be a gateway to other serious issues, like retinal detachment and glaucoma.”

The Brilliant Futures Myopia Management Program seeks to create a new standard of care for children with myopia, according to CooperVision. It provides inclusive practice, child and parent support to create the optimal environment for compliance, satisfaction, clinical outcomes and long-term loyalty. The program features:

• Transparent, defined protocol for care, meaning the patient is fully aware of everything included in the program (including services and lenses) while promoting confidence and efficiency for ECPs.

• Free product shipping and returns, creating no-hassle product availability for the patient, thereby enabling better compliance for the wearer and removing the guesswork from developing and marketing a supply strategy for the ECP.

• An interactive mobile app to keep patients engaged with the practice and their program of care, providing convenient access to myopia management information, lens handling instructions and videos, appointment scheduling and reminders, product ordering and more.

Practices interested in learning more about the Brilliant Futures Myopia Management Program can visit the website. 

CooperVision said it expects to share more information soon on the next round of certification options.